Clinical trial
Magnetic Seizure Therapy (MST) for Severe Mood Disorder
NCT00488748 · Sarah Lisanby, Other · Completed
Key facts
| NCT number | NCT00488748 |
|---|---|
| Title | Magnetic Seizure Therapy (MST) for Severe Mood Disorder |
| Official title | Magnetic Seizure Therapy (MST) for the Treatment of Severe Mood Disorder |
| Lead sponsor | Sarah Lisanby, Other |
| Collaborators | Duke University University of Texas Southwestern Medical Center Stanley Medical Research Institute |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Depression |
| Intervention type | Device |
| Interventions | Thymatron, Magstim Theta |
| Enrollment | 75 |
| Start date | Jun 1, 2007 |
| Primary completion | Aug 1, 2012 |
| Completion | Aug 1, 2012 |
| First posted | Jun 20, 2007 |
| Last update posted | Jan 28, 2015 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: